New Weight Loss Drug Sparks Stock Market Hype: Wave Life Sciences Impresses with Fat Loss and Muscle Gain Data

Wave Life Sciences is a biotech company that is working on novel RNA medications. Currently, a new drug for obesity named WVE-007 is in focus. Wave has now released initial interim results from an early study on this medication, causing the stock market to react explosively. The stock more than doubled in one day and soared to a five-year high. The revolutionary approach: Lose fat, keep muscles WVE-007 is an injection that targets a specific gene in the body: INHBE. This gene is responsible for the production of a protein called Activin E. Activin...